A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

American Journal of Gastroenterology - United States
doi 10.1038/ajg.2012.255

Related search